Supporting Partners

Supporting Institutions

About the A*STAR’s Bioprocessing Technology Institute (BTI)

Bioprocessing Technology Institute (BTI) is a member of the Agency for Science, Technology and Research (A*STAR). Established in 1990 as the Bioprocessing Technology Unit, it was renamed the Bioprocessing Technology Institute (BTI) in 2003. The research institutes mission is to develop manpower capabilities and establish cutting-edge technologies relevant to the bioprocessing community. Some of the key research areas include expression engineering, animal cell technology, stem cell research, microbial fermentation, downstream purification and analytics.

For more information on BTI, please visit https://www.a-star.edu.sg/bti/

 

About Nanyang Technological University, Singapore

A research-intensive public university, Nanyang Technological University, Singapore (NTU Singapore) has 33,500 undergraduate and postgraduate students in the colleges of Engineering, Business, Science, Humanities, Arts, & Social Sciences, and its Interdisciplinary Graduate School. It also has a medical school, the Lee Kong Chian School of Medicine, set up jointly with Imperial College London.

NTU is also home to world-class autonomous institutes – the National Institute of Education, S Rajaratnam School of International Studies, Earth Observatory of Singapore, and Singapore Centre for Environmental Life Sciences Engineering – and various leading research centres such as the Nanyang Environment & Water Research Institute (NEWRI), Energy Research Institute @ NTU (ERI@N) and the Institute on Asian Consumer Insight (ACI).

Ranked 13th in the world, NTU has also been ranked the world’s top young university for the last three years running. The University’s main campus has been named one of the Top 15 Most Beautiful in the World. NTU also has a campus in Novena, Singapore’s medical district.

For more information, visit www.ntu.edu.sg

 

About National University of Singapore (NUS)

A leading global university centred in Asia, the National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education and research, with a focus on Asian perspectives and expertise.

NUS has 17 faculties and schools across three campuses. Its transformative education includes a broad-based curriculum underscored by multi-disciplinary courses and cross-faculty enrichment. Over 38,000 students from 100 countries enrich the community with their diverse social and cultural perspectives.

NUS has three Research Centres of Excellence (RCE) and 30 university-level research institutes and centres. It is also a partner in Singapore’s fifth RCE. The University has established many research partnerships and joint laboratories with academic institutions, industry leaders and government agencies. Research activities are strategic and robust, and NUS is well-known for its research strengths in engineering, life sciences and biomedicine, social sciences and natural sciences. The University also strives to create a supportive and innovative environment to promote creative enterprise within its community.

For more information on NUS, please visit www.nus.edu.sg.

Supporting Foundations

The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. Within this broad mission, BWF has two primary goals:

To help scientists early in their careers develop as independent investigators.

To advance fields in the basic biomedical sciences that are undervalued or in need of particular encouragement.

BWF’s financial support is channeled primarily through competitive peer-reviewed award programs.

BWF makes grants primarily to degree-granting institutions on behalf of individual researchers, who must be nominated by their institutions. To complement these competitive award programs, BWF also makes grants to nonprofit organizations conducting activities intended to improve the general environment for science.

A Board of Directors comprising distinguished scientists and business leaders governs BWF.  BWF was founded in 1955 as the corporate foundation of the pharmaceutical firm Burroughs Wellcome Co. In 1993, a generous gift from the Wellcome Trust in the United Kingdom, enabled BWF to become fully independent from the company, which was acquired by Glaxo in 1995. BWF has no affiliation with any corporation.

 

Lee Foundation

Lee Foundation was established in 1952 by philanthropist and businessman Mr Lee Kong Chian. The foundation seeks to aid the advancement of education, medicine and cultural activities; helping the poor; and assisting victims of fire, flood and famine and the carrying out of other philanthropic work. The Lee Foundation is the largest private charitable foundation in Singapore and is said to have donated close to one billion dollars. The varied recipients include social welfare for the less privileged, the arts, medical assistance, disaster relief, community outreach, women issues and sports. In keeping with the family’s private and modest ways, not all the beneficiaries of the Lee Foundation are made known. Among its notable contributions include a S$60-million donation towards the building of the new National Library in 2003, a S$50-million donation to the Singapore Management University in 2004, and S$150-million to Nanyang Technological University’s new medical school in 2011.

The generosity of the foundation has earned them many accolades such as the Distinguished Patron of the Arts Award by the National Arts Council for several years, and the National Volunteerism and Philanthropy Award Special Recognition Award in 2004.

Supporting Media

Asian Hospital & Healthcare Management is a bi-annual magazine from Ochre Media. It is the leading Healthcare title in print as well as digital versions serving the information needs of key executives from the world’s leading Healthcare providers. Asian Hospital & Healthcare Management covers important issues and trends shaping the future of the Healthcare industry across Asia and rest of the world. It offers dedicated, reliable and accurate coverage of the industry’s progress and incisive analysis to help its readers make informed decisions to stay ahead of the competition.

 

Virologica Sinica is an academic journal aims at presenting the cutting-edge basic and applied research on viruses all over the world. The journal publishes peer-reviewed original research articles and reviews, as well as commentaries and letters to the editor, to encompass the latest developments in all branches of virology, including research on animal, plant and microbe viruses. The journal welcomes articles on virus discovery, viral pathogenesis, virus-host interaction, vaccine development, antiviral agents and therapies, and virus related biotechniques. Virologica Sinica, the official journal of Chinese Society for Microbiology, will serve as a platform for the communication and exchange of academic information and ideas in an international context.

The current editor-in-chief is prof. Zhengli Shi. The journal is indexed by many international databases: Science Citation Index Expanded, Journal Citation Reports(JCR), PubMed/Medline, Scopus,  Google Scholar, SCImago, and etc.

 

Viruses (ISSN 1999-4915) is an open access journal that provides an advanced forum for studies of viruses. Our goal is to publish high-impact articles of broad interest to the virology community and to serve as a forum for major developments in virology research. The journal publishes reviews, regular research papers, communications, conference reports, short notes and commentaries. It is free for readers, with publishing fees paid by authors or their institutions. There is no restriction on the length of published articles or on the use of color illustrations. All submitted manuscripts undergo rigorous peer review prior to publication.

Viruses is indexed by the Science Citation Index Expanded (Web of Science), MEDLINE (PubMed) and other databases. Full-text available in PubMed Central. Manuscripts are peer-reviewed and a first decision provided to authors approximately 33 days after submission; acceptance to publication is undertaken in 8 days.

Supporting Event

LMCE2016_banner